Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.57 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3952217 | 0.90 | HRH3 (0.58) | HRH3KDM4EALDH1A1L3MBTL1KMT2A | |
| SCHEMBL3383896 | 0.88 | OXTR (0.48) | HRH3ACHEKDM4EALDH1A1POLB | |
| SCHEMBL3946642 | 0.88 | KDM4E (0.57) | HRH3KDM4EALDH1A1KMT2A | |
| SCHEMBL3950725 | 0.87 | HRH3 (0.51) | HRH3KDM4EALDH1A1L3MBTL1KMT2A | |
| SCHEMBL3388056 | 0.86 | ACHE (0.51) | HRH3ACHEKDM4EALDH1A1POLB | |
| SCHEMBL3952642 | 0.86 | HRH3 (0.58) | HRH3KDM4EALDH1A1L3MBTL1MGLL | |
| SCHEMBL3387912 | 0.85 | KDM4E (0.60) | HRH3ACHEKDM4EALDH1A1POLB | |
| SCHEMBL3383846 | 0.85 | KDM4E (0.49) | HRH3ACHEKDM4EALDH1A1POLB | |
| SCHEMBL3391345 | 0.84 | OXTR (0.51) | KDM4EALDH1A1POLBL3MBTL1KMT2A | |
| SCHEMBL3388648 | 0.84 | KDM4E (0.56) | HRH3ACHEKDM4EALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101605757-A | Be used for (indoles-4-yl) of obesity treatment-or (indoles-5-yl)-piperazinyl methanone derivatives | HOFFMANN LA ROCHE (CH) | 2009-12-16 | — | — | CN | claimed |
| US-7557108-B2 | (Indol-4-yl) or (indol-5-yl)-piperazinylmethanones | HOFFMANN-LA ROCHE INC. (US) | 2009-07-07 | — | — | US | claimed |
| CN-101605757-A | Be used for (indoles-4-yl) of obesity treatment-or (indoles-5-yl)-piperazinyl methanone derivatives | HOFFMANN LA ROCHE (CH) | 2009-12-16 | — | — | CN | disclosed |
| US-7557108-B2 | (Indol-4-yl) or (indol-5-yl)-piperazinylmethanones | HOFFMANN-LA ROCHE INC. (US) | 2009-07-07 | — | — | US | disclosed |
| US-20080188486-A1 | (INDOL-4-YL) OR (INDOL-5-YL)-PIPERAZINYLMETHANONES | F. HOFFMANN-LA ROCHE AG (CH) | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080188486-A1 | (INDOL-4-YL) OR (INDOL-5-YL)-PIPERAZINYLMETHANONES | HRH4, HRH3, H1-3 | HRH3 2/4885ACHE 1068/4885KDM4E 818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.